233 related articles for article (PubMed ID: 10610645)
1. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.
Schramm C; Schirmacher P; Helmreich-Becker I; Gerken G; zum Büschenfelde KH; Lohse AW
Ann Intern Med; 1999 Dec; 131(12):943-6. PubMed ID: 10610645
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Holtmeier J; Leuschner U
Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
[TBL] [Abstract][Full Text] [Related]
4. Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis.
Fang YQ; Lv DX; Jia W; Li J; Deng YQ; Wang Y; Yu M; Wang GQ
Medicine (Baltimore); 2014 Oct; 93(20):e104. PubMed ID: 25365404
[TBL] [Abstract][Full Text] [Related]
5. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
Mitchell SA; Bansi DS; Hunt N; Von Bergmann K; Fleming KA; Chapman RW
Gastroenterology; 2001 Oct; 121(4):900-7. PubMed ID: 11606503
[TBL] [Abstract][Full Text] [Related]
6. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of cholestatic liver diseases].
Gatzen M; Pausch J
Med Klin (Munich); 2002 Mar; 97(3):152-9. PubMed ID: 11957790
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis.
Komatsu K; Shimosegawa T; Kikuchi S; Uchi M; Maruhama Y; Kisara N; Ueno Y; Toyota T
Intern Med; 2000 Dec; 39(12):1049-53. PubMed ID: 11197788
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.
van Hoogstraten HJ; Wolfhagen FH; van de Meeberg PC; Kuiper H; Nix GA; Becx MC; Hoek AC; van Houte DP; Rijk MC; Salemans JM; Scherpenisse J; Schrijver M; Smit AM; Spoelstra P; Stadhouders PH; Tan TG; Hop WC; ten Kate FJ; vanBerge-Henegouwen GP; Schalm SW; van Buuren HR
J Hepatol; 1998 Sep; 29(3):417-23. PubMed ID: 9764988
[TBL] [Abstract][Full Text] [Related]
10. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
Färkkilä M; Karvonen AL; Nurmi H; Nuutinen H; Taavitsainen M; Pikkarainen P; Kärkkäinen P
Hepatology; 2004 Dec; 40(6):1379-86. PubMed ID: 15565569
[TBL] [Abstract][Full Text] [Related]
11. Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Stokkeland K; Höijer J; Bottai M; Söderberg-Löfdal K; Bergquist A
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1860-1866.e1. PubMed ID: 30448601
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent.
Mueller T; Bianchi L; Menges M
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):232-6. PubMed ID: 18301306
[TBL] [Abstract][Full Text] [Related]
13. Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine.
Kozaiwa K; Tajiri H; Sawada A; Tada K; Etani Y; Miki K; Okada S
J Gastroenterol Hepatol; 1998 Aug; 13(8):825-9. PubMed ID: 9736177
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy.
Zen Y; Grammatikopoulos T; Heneghan MA; Vergani D; Mieli-Vergani G; Portmann BC
Am J Surg Pathol; 2012 Oct; 36(10):1555-61. PubMed ID: 22982898
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Stiehl A
Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study.
Lindor KD; Jorgensen RA; Anderson ML; Gores GJ; Hofmann AF; LaRusso NF
Am J Gastroenterol; 1996 Mar; 91(3):511-5. PubMed ID: 8633500
[TBL] [Abstract][Full Text] [Related]
17. Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?
van Milligen de Wit AW; Kuiper H; Camoglio L; van Bracht J; Jones EA; Tytgat GN; van Deventer SJ
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):129-36. PubMed ID: 10102223
[TBL] [Abstract][Full Text] [Related]
18. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
Charatcharoenwitthaya P; Angulo P; Enders FB; Lindor KD
Hepatology; 2008 Jan; 47(1):133-42. PubMed ID: 17992695
[TBL] [Abstract][Full Text] [Related]
19. The medical management of primary sclerosing cholangitis.
Cullen SN; Chapman RW
Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
[TBL] [Abstract][Full Text] [Related]
20. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group.
Lindor KD
N Engl J Med; 1997 Mar; 336(10):691-5. PubMed ID: 9041099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]